Skip to main content
Premium Trial:

Request an Annual Quote

President Biden Signs Spending Bill, Boosting NIH, CDC, and FDA Budgets

NEW YORK – President Joe Biden signed into law a $1.65 trillion spending bill that, in addition to averting a government shutdown, increases the budgets of the US Food and Drug Administration, National Institutes of Health, and the Centers for Disease Control and Prevention.

Under the bill, the FDA receives $3.5 billion in discretionary funding, representing a $226 million year-over-year increase and bringing total funding, including revenue from user fees, to $6.6 billion.

The funding includes specific increases targeted at addressing the opioid crisis, medical supply chain issues, medical device cybersecurity, and increasing and strengthening in-person inspections of foreign drug manufacturers.

The bill also appropriates $50 million to accelerate medical product development as authorized in the 21st Century Cures Act.

The bill provides $47.5 billion for the NIH, a year-over-year increase of $2.5 billion. Funding includes $7.3 billion for the National Cancer Institute, including $216 million for the NCI component of the Cancer Moonshot; $3.7 billion for research into Alzheimer's disease and other dementias; $75 million for expanded access and activities authorized in the ACT for ALS Act; $57 million in expanded support for minority-serving institutions and health disparities research; $3.3 billion for HIV/AIDS research; and $270 million for universal flu vaccine research, among others.

The bill provides $9.2 billion for the CDC, an increase of $760 million above fiscal year 2022 funding.

Over half of the increased funding is directed at public health infrastructure investments. These include $350 million for nationwide public health infrastructure and capacity; $175 million to modernize public health data surveillance and analytics; $71 million in public health workforce initiatives; $293 million for global public health protection; $187 million for the National Center for Health Statistics; $735 million for public health emergency preparedness cooperative agreements; and $197 million for the antibiotic resistance initiative.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.